EUVIMEDEUVIMED entdecken
Leserbrief

Comments on: Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients

Abbas Iqbal iD, Abubakar Afzal iD, Zaib Un Nisa iD

International Journal of Rheumatic Diseases · 2026-11 · 29 (11)

DOI: 10.1111/1756-185x.70965 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 08.11.2026. Verfasst von Abbas Iqbal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Royal College of Surgeons Ireland, Dublin, Ireland. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Royal College of Surgeons Ireland, Dublin, Ireland.
  • Bannu Medical College, Bannu, Kpk, Pakistan.
  • Northwest School of Medicine, Peshawar, Pakistan.

ORCID-Profile: Abbas Iqbal, Abubakar Afzal, Zaib Un Nisa

Zitieren

APA

Iqbal, A., Afzal, A., & Nisa, Z. U. (2026). Comments on: Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients. International Journal of Rheumatic Diseases, 29(11). https://doi.org/10.1111/1756-185x.70965

Vancouver

Iqbal A, Afzal A, Nisa ZU. Comments on: Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients. International Journal of Rheumatic Diseases. 2026;29(11). doi:10.1111/1756-185x.70965

BibTeX
@article{Iqbal2026,
  author = {Iqbal, Abbas and Afzal, Abubakar and Nisa, Zaib Un},
  title = {Comments on: Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {11},
  doi = {10.1111/1756-185x.70965}
}
Kostenlos starten →